Litcius/Paper detail

Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial

Henry J.C. de Vries, Myrthe de Laat, Vita W. Jongen, Titia Heijman, Carolien M. Wind, Anders Boyd, Jolinda de Korne-Elenbaas, Alje P. van Dam, Maarten F. Schim van der Loeff, Sylvia M. Bruisten, Elske Hoornenborg, Mirjam J. Knol, Ron A. A. Mathôt, Jan M. Prins

2022The Lancet Infectious Diseases61 citationsDOIOpen Access PDF

Topics & Concepts

ErtapenemCeftriaxoneMedicineFosfomycinNeisseria gonorrhoeaeRandomized controlled trialGentamicinInternal medicineSurgeryAntibioticsAntibiotic resistanceMicrobiologyBiologyImipenemReproductive tract infections researchBacterial Infections and VaccinesVirology and Viral Diseases
Efficacy of ertapenem, gentamicin, fosfomycin, and ceftriaxone for the treatment of anogenital gonorrhoea (NABOGO): a randomised, non-inferiority trial | Litcius